Brokerages Set Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Price Target at $23.67
Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) have received a consensus rating of “Buy” from the eight research firms that are covering the firm, Marketbeat.com reports. Eight research analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have covered the stock in the last […]
Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Free Report) have received a consensus rating of “Buy” from the eight research firms that are covering the firm, Marketbeat.com reports. Eight research analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have covered the stock in the last […]
